Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)

Abstract Background Since the index case was reported in China, COVID-19 has led to the death of at least 4 million people globally. Although there are some vaccine cocktails in circulation, the emergence of more virulent variants of SARS-CoV-2 may make the eradication of COVID-19 more difficult. Ns...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tolulope Peter Saliu, Haruna I. Umar, Olawale Johnson Ogunsile, Micheal O. Okpara, Noriyuki Yanaka, Olusola Olalekan Elekofehinti
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
Acceso en línea:https://doaj.org/article/991ed5dba0694b008f28b5429436e1ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:991ed5dba0694b008f28b5429436e1ad
record_format dspace
spelling oai:doaj.org-article:991ed5dba0694b008f28b5429436e1ad2021-11-14T12:32:56ZMolecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)10.1186/s43141-021-00273-52090-5920https://doaj.org/article/991ed5dba0694b008f28b5429436e1ad2021-11-01T00:00:00Zhttps://doi.org/10.1186/s43141-021-00273-5https://doaj.org/toc/2090-5920Abstract Background Since the index case was reported in China, COVID-19 has led to the death of at least 4 million people globally. Although there are some vaccine cocktails in circulation, the emergence of more virulent variants of SARS-CoV-2 may make the eradication of COVID-19 more difficult. Nsp16 is an S-adenosyl-L-Methionine-dependent methyltransferase that plays an important role in SARS-CoV-2 viral RNA cap formation—a crucial process that confers viral stability and prevents virus detection by cell innate immunity mechanisms. This unique property makes nsp16 a promising molecular target for COVID-19 drug design. Thus, this study aimed to identify potent phytocompounds that can effectively inhibit SARS-CoV-2 nsp16. We performed in silico pharmacokinetic screening and molecular docking studies using 100 phytocompounds—isolated from fourteen Nigerian plants—as ligands and nsp16 (PDB: 6YZ1) as the target. Results We found that only 59 phytocompounds passed the drug-likeness analysis test. However, after the docking analysis, only six phytocompounds (oxopowelline, andrographolide, deacetylbowdensine, 11, 12-dimethyl sageone, sageone, and quercetin) isolated from four Nigerian plants (Crinum jagus, Andrographis paniculata, Sage plants (Salvia officinalis L.), and Anacardium occidentale) showed good binding affinity with nsp16 at its active site with docking score ranging from − 7.9 to − 8.4 kcal/mol. Conclusions Our findings suggest that the six phytocompounds could serve as therapeutic agents to prevent viral survival and replication in cells. However, further studies on the in vitro and in vivo inhibitory activities of these 6 hit phytocompounds against SARS-CoV-2 nsp16 are needed to confirm their efficacy and dose.Tolulope Peter SaliuHaruna I. UmarOlawale Johnson OgunsileMicheal O. OkparaNoriyuki YanakaOlusola Olalekan ElekofehintiSpringerOpenarticleCOVID-19SARS-CoV-2Nsp16PhytocompoundsPharmacokineticsBiotechnologyTP248.13-248.65GeneticsQH426-470ENJournal of Genetic Engineering and Biotechnology, Vol 19, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
Nsp16
Phytocompounds
Pharmacokinetics
Biotechnology
TP248.13-248.65
Genetics
QH426-470
spellingShingle COVID-19
SARS-CoV-2
Nsp16
Phytocompounds
Pharmacokinetics
Biotechnology
TP248.13-248.65
Genetics
QH426-470
Tolulope Peter Saliu
Haruna I. Umar
Olawale Johnson Ogunsile
Micheal O. Okpara
Noriyuki Yanaka
Olusola Olalekan Elekofehinti
Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
description Abstract Background Since the index case was reported in China, COVID-19 has led to the death of at least 4 million people globally. Although there are some vaccine cocktails in circulation, the emergence of more virulent variants of SARS-CoV-2 may make the eradication of COVID-19 more difficult. Nsp16 is an S-adenosyl-L-Methionine-dependent methyltransferase that plays an important role in SARS-CoV-2 viral RNA cap formation—a crucial process that confers viral stability and prevents virus detection by cell innate immunity mechanisms. This unique property makes nsp16 a promising molecular target for COVID-19 drug design. Thus, this study aimed to identify potent phytocompounds that can effectively inhibit SARS-CoV-2 nsp16. We performed in silico pharmacokinetic screening and molecular docking studies using 100 phytocompounds—isolated from fourteen Nigerian plants—as ligands and nsp16 (PDB: 6YZ1) as the target. Results We found that only 59 phytocompounds passed the drug-likeness analysis test. However, after the docking analysis, only six phytocompounds (oxopowelline, andrographolide, deacetylbowdensine, 11, 12-dimethyl sageone, sageone, and quercetin) isolated from four Nigerian plants (Crinum jagus, Andrographis paniculata, Sage plants (Salvia officinalis L.), and Anacardium occidentale) showed good binding affinity with nsp16 at its active site with docking score ranging from − 7.9 to − 8.4 kcal/mol. Conclusions Our findings suggest that the six phytocompounds could serve as therapeutic agents to prevent viral survival and replication in cells. However, further studies on the in vitro and in vivo inhibitory activities of these 6 hit phytocompounds against SARS-CoV-2 nsp16 are needed to confirm their efficacy and dose.
format article
author Tolulope Peter Saliu
Haruna I. Umar
Olawale Johnson Ogunsile
Micheal O. Okpara
Noriyuki Yanaka
Olusola Olalekan Elekofehinti
author_facet Tolulope Peter Saliu
Haruna I. Umar
Olawale Johnson Ogunsile
Micheal O. Okpara
Noriyuki Yanaka
Olusola Olalekan Elekofehinti
author_sort Tolulope Peter Saliu
title Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
title_short Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
title_full Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
title_fullStr Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
title_full_unstemmed Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
title_sort molecular docking and pharmacokinetic studies of phytocompounds from nigerian medicinal plants as promising inhibitory agents against sars-cov-2 methyltransferase (nsp16)
publisher SpringerOpen
publishDate 2021
url https://doaj.org/article/991ed5dba0694b008f28b5429436e1ad
work_keys_str_mv AT tolulopepetersaliu moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
AT harunaiumar moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
AT olawalejohnsonogunsile moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
AT michealookpara moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
AT noriyukiyanaka moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
AT olusolaolalekanelekofehinti moleculardockingandpharmacokineticstudiesofphytocompoundsfromnigerianmedicinalplantsaspromisinginhibitoryagentsagainstsarscov2methyltransferasensp16
_version_ 1718429181269770240